Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

bladder cancer; radiotherapy; radiosensitisation; molecular subtypes; preclinical studies; bladder cancer cell lines; latent cancer; prostate cancer; autopsy; prognostic index; prediction model; mortality; screening trial; renal cell carcinoma; PD-1; PD-L1; biomarkers; immune checkpoint inhibitors; prostatic neoplasms; positron-emission tomography; decision making; tumor thrombus; metastasectomy; postoperative complications; oncological outcomes; radical cystectomy; AHNAK2; prognosis; dog; comparative oncology; inflammation; prostatic atrophy; preneoplastic lesion; biomarker; urine; machine learning; TRIPOD; liquid biopsy; glutaminase; immunohistochemistry; in situ methods; prostate; PSMA-RLT; 177Lu-PSMA; PSA; mCRPC; urinary bladder neoplasms; Bacillus Calmette–Guérin (BCG); immunotherapy; divergent differentiation; variant morphology; survival; stereotactic body radiotherapy; frail patients; cancer; metastasis; genomic analysis; microenvironment; tumor ecology; game theory; fluorescence confocal microscopy; prostate biopsy; ablation margins; focal therapy; sphingosine 1-phosphate receptor 1; bladder carcinoma; cell migration; epithelial–mesenchymal transition; FTY-720; OIP5; papillary renal cell carcinoma; PLK1; tumorigenesis; therapy; image-guided; magnetic resonance imaging; ultrasonography; biopsy; abiraterone; enzalutamide; docetaxel; novel hormonal therapies; comparative effectiveness; real-world treatment pattern; metastatic prostate cancer; epiplakin; diagnosis; advanced urothelial carcinoma; immune checkpoint inhibitor; prognostic; tumour mutational board; genomic signatures; ctDNA; inflammatory indices; urothelial carcinoma; frailty; prognostic factor; psoas muscle; Hounsfield units; n/a